Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Potential beneficial effects of a gluten-free diet in newly diagnosed children with type 1 diabetes: a pilot study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effects of early and late-onset treatment with carvedilol in an experimental model of aortic regurgitation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. In vitro investigation of Mesenchymal Stem Cell Secretomes molecular mechanisms in β-cell protection

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

  2. Genomic based investigation of phenotypic differences of T1D-derived IPSC-beta cells

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskning

  3. International comparison of glycaemic control in people with type 1 diabetes: an update and extension

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Peptide Antibody Reactivity to Homologous Regions in Glutamate Decarboxylase Isoforms and Coxsackievirus B4 P2C

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

AIM: Gluten-free diet has shown promising effects in preventing type 1 diabetes (T1D) in animals as well as beneficial effects on the immune system. Gluten-free diet at diabetes onset may alter the natural course and outcome of autoimmune diseases such as T1D.

METHODS: In a 12-month study, 15 children newly diagnosed with T1D were instructed to follow a gluten-free diet. Questionnaires were used to evaluate adherence to the gluten-free diet. Partial remission (PR) was defined by insulin dose-adjusted A1c (IDAA1c) ≤9 or stimulated C-peptide (SCP) >300 pmol/L measured 90 min after a liquid mixed meal at the inclusion, six and 12 months after onset. The intervention group was compared with two previous cohorts. Linear mixed models were used to estimate differences between cohorts.

RESULTS: After 6 months, more children on a gluten-free diet tended to have SCP values above 300 pmol/L compared to the European cohort (p = 0.08). The adherence to a gluten-free diet decreased during the 12-month study period. After 1 year there was no difference in SCP levels or percentage in remission according to SCP (p > 0.1). Three times as many children were still in PR based on IDAA1c (p < 0.05). Twelve months after onset HbA1c were 21 % lower and IDAA1c >1 unit lower in the cohort on a gluten-free diet compared to the two previous cohorts (p < 0.001).

CONCLUSION: Gluten-free diet is feasible in highly motivated families and is associated with a significantly better outcome as assessed by HbA1c and IDAA1c. This finding needs confirmation in a randomized trial including screening for quality of life. (Clinicaltrials.gov number NCT02284815).

OriginalsprogEngelsk
TidsskriftSpringerPlus
Vol/bind5
Udgave nummer1
Sider (fra-til)994
ISSN2193-1801
DOI
StatusUdgivet - 2016

ID: 49819957